Ralph Niven

Chief Development Officer at Aerovate Therapeutics

Ralph Niven has over 25 years of broad experience in translational medicine with a specific emphasis on inhaled drug development. Ralph has driven the experimental and clinical development of small molecules and biomolecules employing a variety of delivery systems, at both startups and large pharmaceutical companies.

Links

Previous companies

Alkermes logo
Novartis logo
Amgen logo

Timeline

  • Chief Development Officer

    Current role

View in org chart